• Je něco špatně v tomto záznamu ?

Broadness and specificity: ArdB, ArdA, and Ocr against various restriction-modification systems

AA. Kudryavtseva, E. Cséfalvay, EY. Gnuchikh, DD. Yanovskaya, MA. Skutel, AB. Isaev, SV. Bazhenov, AA. Utkina, IV. Manukhov

. 2023 ; 14 (-) : 1133144. [pub] 20230417

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23009970

ArdB, ArdA, and Ocr proteins inhibit the endonuclease activity of the type I restriction-modification enzymes (RMI). In this study, we evaluated the ability of ArdB, ArdA, and Ocr to inhibit different subtypes of Escherichia coli RMI systems (IA, IB, and IC) as well as two Bacillus licheniformis RMI systems. Furthermore we explored, the antirestriction activity of ArdA, ArdB, and Ocr against a type III restriction-modification system (RMIII) EcoPI and BREX. We found that DNA-mimic proteins, ArdA and Ocr exhibit different inhibition activity, depending on which RM system tested. This effect might be linked to the DNA mimicry nature of these proteins. In theory, DNA-mimic might competitively inhibit any DNA-binding proteins; however, the efficiency of inhibition depend on the ability to imitate the recognition site in DNA or its preferred conformation. In contrast, ArdB protein with an undescribed mechanism of action, demonstrated greater versatility against various RMI systems and provided similar antirestriction efficiency regardless of the recognition site. However, ArdB protein could not affect restriction systems that are radically different from the RMI such as BREX or RMIII. Thus, we assume that the structure of DNA-mimic proteins allows for selective inhibition of any DNA-binding proteins depending on the recognition site. In contrast, ArdB-like proteins inhibit RMI systems independently of the DNA recognition site.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23009970
003      
CZ-PrNML
005      
20230721095400.0
007      
ta
008      
230707s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fmicb.2023.1133144 $2 doi
035    __
$a (PubMed)37138625
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kudryavtseva, Anna A $u Laboratory for Molecular Genetics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia
245    10
$a Broadness and specificity: ArdB, ArdA, and Ocr against various restriction-modification systems / $c AA. Kudryavtseva, E. Cséfalvay, EY. Gnuchikh, DD. Yanovskaya, MA. Skutel, AB. Isaev, SV. Bazhenov, AA. Utkina, IV. Manukhov
520    9_
$a ArdB, ArdA, and Ocr proteins inhibit the endonuclease activity of the type I restriction-modification enzymes (RMI). In this study, we evaluated the ability of ArdB, ArdA, and Ocr to inhibit different subtypes of Escherichia coli RMI systems (IA, IB, and IC) as well as two Bacillus licheniformis RMI systems. Furthermore we explored, the antirestriction activity of ArdA, ArdB, and Ocr against a type III restriction-modification system (RMIII) EcoPI and BREX. We found that DNA-mimic proteins, ArdA and Ocr exhibit different inhibition activity, depending on which RM system tested. This effect might be linked to the DNA mimicry nature of these proteins. In theory, DNA-mimic might competitively inhibit any DNA-binding proteins; however, the efficiency of inhibition depend on the ability to imitate the recognition site in DNA or its preferred conformation. In contrast, ArdB protein with an undescribed mechanism of action, demonstrated greater versatility against various RMI systems and provided similar antirestriction efficiency regardless of the recognition site. However, ArdB protein could not affect restriction systems that are radically different from the RMI such as BREX or RMIII. Thus, we assume that the structure of DNA-mimic proteins allows for selective inhibition of any DNA-binding proteins depending on the recognition site. In contrast, ArdB-like proteins inhibit RMI systems independently of the DNA recognition site.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cséfalvay, Eva $u Laboratory of Structural Biology and Bioinformatics, Institute of Microbiology, Academy of Sciences of the Czech Republic, Nové Hrady, Czechia
700    1_
$a Gnuchikh, Evgeniy Yu $u Kurchatov Genomic Center, National Research Center Kurchatov Institute, Moscow, Russia
700    1_
$a Yanovskaya, Darya D $u Center of Cellular and Molecular Biology, Skolkovo Institute of Science and Technology, Moscow, Russia
700    1_
$a Skutel, Mikhail A $u Center of Cellular and Molecular Biology, Skolkovo Institute of Science and Technology, Moscow, Russia
700    1_
$a Isaev, Artem B $u Center of Cellular and Molecular Biology, Skolkovo Institute of Science and Technology, Moscow, Russia
700    1_
$a Bazhenov, Sergey V $u Laboratory for Molecular Genetics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia $u Laboratory for Microbiology, BIOTECH University, Moscow, Russia $u Faculty of Physics, HSE University, Moscow, Russia
700    1_
$a Utkina, Anna A $u Laboratory for Molecular Genetics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia
700    1_
$a Manukhov, Ilya V $u Laboratory for Molecular Genetics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia $u Laboratory for Microbiology, BIOTECH University, Moscow, Russia $u Faculty of Physics, HSE University, Moscow, Russia
773    0_
$w MED00181714 $t Frontiers in microbiology $x 1664-302X $g Roč. 14, č. - (2023), s. 1133144
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37138625 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095353 $b ABA008
999    __
$a ok $b bmc $g 1958583 $s 1196234
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 14 $c - $d 1133144 $e 20230417 $i 1664-302X $m Frontiers in microbiology $n Front Microbiol $x MED00181714
LZP    __
$a Pubmed-20230707

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...